Filing Details

Accession Number:
0001179110-14-016754
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-18 16:37:51
Reporting Period:
2014-11-14
Filing Date:
2014-11-18
Accepted Time:
2014-11-18 16:37:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1065087 Albany Molecular Research Inc AMRI Services-Commercial Physical & Biological Research (8731) 141742717
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449207 R Steven Hagen 26 Corporate Circle
Albany NY 12203
Svp Pharmaceutical Dev & Mfg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-14 10,500 $8.31 41,433 No 4 M Direct
Common Stock Disposition 2014-11-14 10,500 $16.06 30,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to Purchase Common Stock Acquisiton 2014-11-14 10,500 $8.31 10,500 $8.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-16 No 4 M Direct
Footnotes
  1. 100% of the grant is time based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (March 16, 2009). The 10,500 shares being exercised represent the total vested grant.